Abstract
Urinary tract infections (UTIs) are a major cause of hospital-acquired infections, and up to 80% of these are linked to urinary catheters. The biofilm formation of uropathogenic E. coli plays a critical role in the development of catheter-associated urinary tract infections (CAUTIs). This study aimed to develop a silicone elastomer material incorporating green-synthesized zinc oxide nanoparticles for potential urinary catheter applications and assess its antibiofilm efficacy against uropathogenic Escherichia coli (UPEC). E. coli was identified by the BD PhoenixTM system and 16S rRNA gene sequencing. ZnO NPs were synthesized through a green method using Crataegus azarolus leaf extract as a biological reducing and stabilizing agent. NPs were incorporated into a silicone matrix at different concentrations (0 wt%, 0.5 wt%, 1 wt% and 1.5 wt%) to produce ZnO-functionalized silicone elastomer specimens for potential urinary catheter applications, and then their antibiofilm activity was assessed through a 96-well microtiter assay. NPs and nanocomposites were characterized through various spectroscopic techniques using XRD, FTIR, and FESEM. In the 1.5 wt% ZnO NPs–silicone elastomer specimen, biofilm formation by E. coli ATCC 25922 and the clinical isolate were significantly reduced by 86.94% and 78.40%, respectively, compared to the control silicone elastomer specimen for potential urinary catheter application. The present findings suggest that green synthesized ZnO NPs provide a promising and biocompatible approach to reducing UPEC biofilm formation when incorporated into silicone elastomer specimens for urinary catheter application. Furthermore, this method may help reduce CAUTIs in clinical settings.